Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03780205 · ClinicalTrials.gov registry record
Bilateral and Unilateral Amblyopia Treatment Study
A clinical trial, sponsored by Salus University.
- Terminated
- Registry status
- 1
- Enrollment target
NCT03780205: Clinical Trial study, sponsored by Salus University.
NCT03780205 is a clinical trial that was terminated before completion, run by Salus University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03780205 was terminated before completion, sponsored by Salus University.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose for this study is to investigate spectacle compliance and treatment outcome in bilateral and unilateral refractive amblyopia in children age 3 to \<10 years old. Specifically, how frequently and for what duration is spectacle wear necessary to maximize best-corrected visual acuity by spectacle correction alone.
Primary Outcome
visual acuity change from the baseline in logMAR
Interventions
- OTHER Prescription glasses for bilateral amblyopia
- OTHER Prescription glasses for unilateral amblyopia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-03-20 |
| Est. Completion | 2020-07-07 |
Why NCT03780205 stopped before completion
NCT03780205 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Prescription glasses for bilateral amblyopia is the first listed.
NCT03780205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03780205 about?
NCT03780205 is a clinical study titled "Bilateral and Unilateral Amblyopia Treatment Study". The purpose for this study is to investigate spectacle compliance and treatment outcome in bilateral and unilateral refractive amblyopia in children age 3 to \<10 years old. Specifically, how frequently and for what duration is spectacle wear necessary to maximize best-corrected visual acuity by spe...
What is the current status of trial NCT03780205?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2019-03-20. Estimated completion is 2020-07-07.
What interventions are being tested in trial NCT03780205?
The interventions under investigation include: Prescription glasses for bilateral amblyopia (OTHER), Prescription glasses for unilateral amblyopia (OTHER).
Who is sponsoring clinical trial NCT03780205?
This trial is sponsored by Salus University, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI